Effects of food on the clinical pharmacokinetics of anticancer agents: Underlying mechanisms and implications for oral chemotherapy by SINGH, Brahma N, MALHOTRA, Bimal K

Get full text

Pharmacokinetics of Tolterodine in Japanese and Koreans: Physiological and Stochastic Assessment of Ethnic Differences by Oishi, Masayo, Chiba, Koji, Malhotra, Bimal, Suwa, Toshio

Get full text

pharmacokinetic profile of fesoterodine 8 mg with daytime or nighttime dosing by Malhotra, Bimal K, Crownover, Penelope H, LaBadie, Robert, Glue, Paul, MacDiarmid, Scott A

Get full text

Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone by Gandelman, Kuan, Lamson, Michael, Salageanu, Joanne, Bramson, Candace, Matschke, Kyle, Malhotra, Bimal

Get full text

Single- and multiple-dose study to evaluate pharmacokinetics, safety and tolerability in healthy volunteers: A comparison of extended-release oxycodone with sequestered naltrexone... by Gandelman, Kuan, Lamson, Michael, Bramson, Candace, Matschke, Kyle, Salageanu, Joanne, Malhotra, Bimal

Get full text

Modeling dose-response relationships of the effects of fesoterodine in patients with overactive bladder by Cardozo, Linda, Khullar, Vik, El-Tahtawy, Ahmed, Guan, Zhonghong, Malhotra, Bimal, Staskin, David

Get full text

Evaluation of the Effect of Abrocitinib on Drug Transporters by Integrated Use of Probe Drugs and Endogenous Biomarkers by Vourvahis, Manoli, Byon, Wonkyung, Chang, Cheng, Le, Vu, Diehl, Annette, Graham, Daniela, Tripathy, Sakambari, Raha, Nancy, Luo, Lina, Mathialagan, Sumathy, Dowty, Martin, Rodrigues, A. David, Malhotra, Bimal

Get full text

Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug‐Drug Interaction for Fesoterodine When Coadministered With Mirabegron by Lin, Jian, Goosen, Theunis C., Tse, Susanna, Yamagami, Hidetomi, Malhotra, Bimal

Get full text

15433 Assessment of cytochrome P450 3A inhibition and induction of abrocitinib: Midazolam drug-drug interaction (DDI) study and oral contraceptive DDI study by Wang, Xiaoxing, Huh, Yeamin, Curto, Madelyn, Chan, Gary, Dowty, Martin E., O'Gorman, Melissa, Tripathy, Sakambari, Malhotra, Bimal, Gupta, Pankaj

Get full text

The effects of reformulation: Improved therapeutic index by MacDiarmid, Scott, Sandage, Bobby W., Malhotra, Bimal K.

Get full text

Fesoterodine treatment of pediatric patients with neurogenic detrusor overactivity: A 24-week, randomized, open-label, phase 3 study by Kitta, Takeya, Darekar, Amanda, Malhotra, Bimal, Shahin, Mohamed H., Jones, Philip, Lindsay, Monica, Mallen, Sharon, Nieto, Alejandra, Crook, Tim J.

Get full text

Meta‐Analysis of Noncompartmental Pharmacokinetic Parameters to Evaluate the Impact of CYP2C19 and CYP2C9 Genetic Polymorphisms on Abrocitinib Exposure by Fostvedt, Luke, Liu, Jian, Wang, Xiaoxing, Li, Yinhua, Johnson, Jillian, Wood, Linda, Dowty, Martin, Malhotra, Bimal, Valdez, Hernan, Nicholas, Timothy, Xue, Wei

Get full text

Comparison of pharmacokinetic variability of fesoterodine vs. tolterodine extended release in cytochrome P450 2D6 extensive and poor metabolizers by Malhotra, Bimal, Darsey, Edress, Crownover, Penelope, Fang, Juanzhi, Glue, Paul

Get full text

Evaluation of drug–drug interactions with fesoterodine by Malhotra, Bimal, Sachse, Richard, Wood, Nolan

Get full text

Effects of the moderate CYP3A4 inhibitor, fluconazole, on the pharmacokinetics of fesoterodine in healthy subjects by Malhotra, Bimal, Dickins, Maurice, Alvey, Christine, Jumadilova, Zhanna, Li, Xiaoxi, Duczynski, Gregory, Gandelman, Kuan

Get full text

Comparing abrocitinib and dupilumab in the treatment of atopic dermatitis: a plain language summary by Bieber, Thomas, Simpson, Eric L, Silverberg, Jonathan I, Thaçi, Diamant, Paul, Carle, Pink, Andrew E, Kataoka, Yoko, Chu, Chia-Yu, DiBonaventura, Marco, Rojo, Ricardo, Antinew, Jeremias, Ionita, Ileana, Sinclair, Rodney, Forman, Seth, Zdybski, Jacek, Biswas, Pinaki, Malhotra, Bimal, Zhang, Fan, Valdez, Hernan

Get full text

Abuse Potential Study of ALO-02 (Extended-Release Oxycodone Surrounding Sequestered Naltrexone) Compared with Immediate-Release Oxycodone Administered Orally to Nondependent Recrea... by Setnik, Beatrice, Bass, Almasa, Bramson, Candace, Levy-Cooperman, Naama, Malhotra, Bimal, Matschke, Kyle, Geoffroy, Pierre, Sommerville, Kenneth W., Wolfram, Gernot

Get full text

Comparative Biotransformation of Radiolabeled [14C]Omapatrilat and Stable-labeled [13C2]Omapatrilat after Oral Administration to Rats, Dogs, and Humans by Iyer, Ramaswamy A., Malhotra, Bimal, Khan, Sanaullah, Mitroka, James, Bonacorsi, Samuel, Waller, Stephen C., Rinehart, J. Kent, Kripalani, Kishin

Get full text

Intranasal administration of crushed ALO-02 (extended-release oxycodone with sequestered naltrexone): A randomized, controlled abuse-potential study in nondependent recreational op... by Setnik, Beatrice, Bramson, Candace, Bass, Almasa, Levy-Cooperman, Naama, Malhotra, Bimal, Matschke, Kyle, Sommerville, Kenneth W., Wolfram, Gernot, Geoffroy, Pierre

Get full text

Population Pharmacokinetics of Atorvastatin and Its Active Metabolites in Children and Adolescents With Heterozygous Familial Hypercholesterolemia: Selective Use of Informative Pri... by Knebel, William, Gastonguay, Marc R., Malhotra, Bimal, El-Tahtawy, Ahmed, Jen, Frank, Gandelman, Kuan

Get full text